Relative Bioavailability Study on a Single Dose of GW842166X in Healthy Male and Female Subjects.

NCT00536497 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Compound terminated

Conditions

Healthy Subjects

Interventions

DRUG: GW842166X

Sponsor

GlaxoSmithKline